Acute Myeloid Leukemia Treatment Options Expand With Recent FDA Approvals

13:30 EST 30 Nov 2018 | Cancer Connect

FDA Approves Venclexta, Daurismo, and Xospata Precision Cancer Medicines for Treatment of Acute Myeloid Leukemia

More From BioPortfolio on "Acute Myeloid Leukemia Treatment Options Expand With Recent FDA Approvals"